Insulin resistance in chronic hepatitis B and C

Indian Journal of Gastroenterology

Volumn 25, Issue 6, 2006, Pages 286-289

  Alizadeh, Amir Houshang Mohammad ^a,d   Fallahian, Farahnaz ^a   Alavian, Seyed Moayed ^a   Ranjbar, Mitra ^c   Hedayati, Mehdi ^a   Rahimi, Farzaneh ^a   Khedmat, Hossein ^b   Etemadi, Arash ^a   Zali, Mohammad Reza ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; C PEPTIDE; CHOLESTEROL; FERRITIN; HEMOGLOBIN; INSULIN; IRON; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; STEATOSIS; WAIST CIRCUMFERENCE; BLOOD; FATTY LIVER; GENETICS; GENOTYPE; HEPATITIS C VIRUS; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; VIRUS LOAD;

ADULT; DNA, VIRAL; FATTY LIVER; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; LIVER CIRRHOSIS; MALE; VIRAL LOAD;

EID: 33947533792     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003;125:1695-704.
2. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;11:431-5.
3. Ishak K, Baptista A, Bionchi L, Callea F, Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
4. MacSween RNM, Burt AD, Portman BC, Ishak KG, Scheuer PJ, Anthony PP. Pathology of the Liver. 4th ed. Harcourt-Churchill Livingstone. 2002: p. 260.
5. Custro N, Carrocio A, Ganci A, Scafidi V, Campagna P, Di Prima L, et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001;27(4 Pt 1):476-81.
6. Bonora E, Coscelli C, Orioli S, Camb R, Buzzell G, Genlini P, et al. Hyperinsulinemia of chronic active hepatitis: impaired insulin removal rather than pancreatic hypersection. Horm Metab Res 1984;16:111-4.
7. Greco AV, Mingone G, Mari A, Capristo E, Manco M, Gasbarrini G. Mechanisms of hyperinsulinemia in Child's grade B liver cirrhosis investigated in free living conditions. Gut 2002;51:870-5.
8. Petrides AS. Liver disease and diabetes mellitus. Diabetes Rev 1994;2:2-18.
9. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-27.
10. Etemadi A, Saadat N, Pezeshk P, Mirbolooki M, Habibi Moini AS, Azizi F. Metabolic syndrome and development of diabetes and impaired glucose tolerance. Irn J Endocrinol Metabol 2004;6:.21-4.
11. Azizi A, Tariq AR. Preliminary human fasting plasma insulin values by using immulite insulin kit. Available at: www.E-imj.com/voll-no1/vol-no1- E2html.
12. Brunt EM, Ramrahkiani S, Cordes BG, Neuschwander-Tetri BA, Janney CG, Bacon BR, et al. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 2003;16:49-56.
13. Tetri BA. Impact of nonalcoholic fatty liver disease on hepatitis C. Hepatitis Annual Update 2004. Available at: http://www.aids-chushi.or. jp/c4/hcv/HCV.html.
14. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Cloustone A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-9.
15. Clouston AD, Jonsson JR, Purdie DM, Macdonald GA, Pandeya N, Shorthouse C, et al. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol 2001;34:314-20.
16. Lai MM. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002;122:568-71.
17. Leart H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002;122:352-65.
18. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/P13-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003;38:1384-92.
19. Negro F. Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always. Hepatology 2002;36:1050-2.
20. Mason AL, Lau JYN, Hoang N, Qian K, Alexander GJM, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-33.
21. Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, Purdie DM, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol 2003;39:1042-8.